Unity Biotechnology Inc (UBX) — Working Capital to Net Assets Ratio
Unity Biotechnology Inc (UBX) has a Working Capital to Net Assets ratio of -4185.9% as of March 2025. Working capital of $8.58 Million (current assets of $17.65 Million minus current liabilities of $9.07 Million) is measured against net assets of $-205.00K. A higher ratio indicates strong short-term liquidity financed by the equity base. See Unity Biotechnology Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Unity Biotechnology Inc Working Capital to Net Assets (2016–2024)
This chart shows how Unity Biotechnology Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of March 2025, the ratio stands at -4185.9%, reflecting working capital of $8.58 Million against net assets of $-205.00K USD. See UBX days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Unity Biotechnology Inc (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Unity Biotechnology Inc from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see UBX stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 231.1% | $15.01 Million | $6.49 Million | $24.27 Million | $9.26 Million | ▲ +94.6 pp |
| 2023 | 136.5% | $38.77 Million | $28.40 Million | $46.60 Million | $7.84 Million | ▲ +21.4 pp |
| 2022 | 115.1% | $76.92 Million | $66.85 Million | $96.53 Million | $19.62 Million | ▼ -9.0 pp |
| 2021 | 124.0% | $73.89 Million | $59.57 Million | $90.50 Million | $16.62 Million | ▲ +19.8 pp |
| 2020 | 104.3% | $86.40 Million | $82.88 Million | $100.87 Million | $14.46 Million | ▲ +11.2 pp |
| 2019 | 93.0% | $112.27 Million | $120.71 Million | $129.49 Million | $17.22 Million | ▼ -4.3 pp |
| 2018 | 97.3% | $156.38 Million | $160.69 Million | $172.97 Million | $16.58 Million | ▲ +8.2 pp |
| 2017 | 89.1% | $80.98 Million | $90.84 Million | $88.88 Million | $7.90 Million | ▲ +305.1 pp |
| 2016 | -216.0% | $89.72 Million | $-41.54 Million | $93.41 Million | $3.69 Million | — |